Connection number-based molecular descriptors of skin cancer drugs

Abstract

Connection number-based molecular descriptors are one type of quantitative measure that provides insight into the connectivity of atoms and bonds within a molecule. The investigation of skin cancer treatments based on connection number-based molecular descriptors requires quantifying the structural features of these pharmaceuticals based on their atom and bond connections. By employing connection number-based descriptors, it is possible to understand the chemical structure and connectivity patterns of these drugs. In this article, we calculated a few connection number-based molecular descriptors for skin cancer drugs, particularly Cobimetinib, Picato, Vismodegib, Odomzo, Imiquimod, Vemurafenib, Daurismo, Trametinib, Fluorouracil, Dacarbazine, Dabrafenib, Encorafenib, and Binimeinib. To summarise, the practical implementation of the research findings presented in the paper allows Dermathera Pharmaceuticals to effectively address obstacles in the process of discovering and developing drugs for skin cancer. The organization enhances its workflow by including molecular descriptors based on connection numbers. This allows for improved chemical selection, accurate prediction of therapy results, and the development of more efficient and safer treatments for patients with skin cancer. This application highlights the concrete advantages of the research in practical pharmaceutical engineering environments.